New cancer clinical trial: A Study of Hormonal Therapy and Apalutamide With or Without Abiraterone Acetate and Prednisone in Newly Diagnosed Prostate Cancers

Published on: February 16, 2018 at 12:00PM
Condition:   Prostate Cancer
Interventions:   Drug: Apalutamide;   Drug: Abiraterone Acetate;   Drug: Prednisone;   Procedure: Radical Prostatectomy;   Procedure: Extended Pelvic lymphadenectomy;   Drug: GnRH agonist/antagonist
Sponsors:   Memorial Sloan Kettering Cancer Center;   Dana-Farber Cancer Institute
Not yet recruiting
http://ift.tt/2GuotHr